Corrigendum to: GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma

Title:Corrigendum to: GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma

Volume: 23 Issue: 11

Author(s): Sitansu S. Nanda, Md Imran Hossain, Heongkyu Ju, Georgia C. Papaefthymiou and Dong Kee Yi*

Affiliation:

• Department of Chemistry, Myongji University, Yongin, 03674, South Korea

Abstract: The author requested to add a co-author after the publication of the original article [1]. In this correction, the author has been added in the article entitled “GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma” in the journal “Current Drug Targets” 2021; 22(13), 1485-1495.

Details of the error and a correction are provided here.

The original editorial can be found online at 10.2174/1389450122666210204203950

We regret any errors and apologize to the readers.

Original:

Sitansu S. Nanda¹, Md Imran Hossain¹, Heongkyu Ju² and Dong Kee Yi¹,*

¹Department of Chemistry, Myongji University, Yongin, 03674, South Korea; ²Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do, South Korea

Corrected:

Sitansu S. Nanda¹, Md Imran Hossain¹, Heongkyu Ju², Georgia C. Papaefthymiou³ and Dong Kee Yi¹,*

¹Department of Chemistry, Myongji University, Yongin, 03674, South Korea; ²Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do, South Korea ³Department of Physics, Villanova University, Villanova, Pennsylvania19085, USA

Cite this article as:

Nanda S. Sitansu, Hossain Imran Md, Ju Heongkyu, Papaefthymiou C. Georgia and Yi Kee Dong*, Corrigendum to: GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma, Current Drug Targets 2022; 23 (11) . https://dx.doi.org/10.2174/138945012311220720160340